Day Nurse capsules

Land: Vereinigtes Königreich

Sprache: Englisch

Quelle: MHRA (Medicines & Healthcare Products Regulatory Agency)

Wirkstoff:

Paracetamol; Pseudoephedrine hydrochloride; Pholcodine

Verfügbar ab:

Haleon UK Ltd

ATC-Code:

N02BE51

INN (Internationale Bezeichnung):

Paracetamol; Pseudoephedrine hydrochloride; Pholcodine

Dosierung:

500mg ; 30mg ; 5mg

Darreichungsform:

Oral capsule

Verabreichungsweg:

Oral

Klasse:

Schedule 5 (CD Inv)

Verschreibungstyp:

Never Valid To Prescribe As A VMP

Produktbesonderheiten:

BNF: ; GTIN: 5000347077814

Gebrauchsinformation

PLEASE READ RIGHT THROUGH THIS LEAFLET BEFORE YOU
START USING THIS MEDICINE.
This medicine is available without prescription, but
you still need to use Day Nurse Capsules carefully to
get the best results from them.
•
Keep this leaflet you may need to read it again.
•
If you have any further questions, ask your
pharmacist.
IN THIS LEAFLET:
1.
What Day Nurse Capsules do
2.
Check before you take Day Nurse Capsules
3.
How to take Day Nurse Capsules
4.
Possible side effects
5.
How to store Day Nurse Capsules
6.
Further information
1.
WHAT DAY NURSE CAPSULES DO
DAY NURSE CAPSULES ARE USED FOR THE DAY-TIME
RELIEF OF THE MAJOR SYMPTOMS OF COLDS, CHILLS AND
INFLUENZA.
The medicine contains three active ingredients.
Paracetamol is a painkiller and reduces
your temperature when you have a fever.
Pseudoephedrine hydrochloride is a decongestant
which opens the airways, helping you breathe more
easily. Pholcodine is a cough suppressant that helps
relieve dry or tickly coughs.
2.
CHECK BEFORE YOU TAKE DAY
NURSE CAPSULES
DO NOT TAKE DAY NURSE
CAPSULES:
•
IF YOU HAVE EVER HAD AN ALLERGIC REACTION to
paracetamol, pseudoephedrine hydrochloride,
pholcodine or any of the other ingredients (listed
in Section 6)
•
if you have ever developed a severe SKIN RASH
or skin that peels, BLISTERS or SORES in the mouth
after taking Day Nurse.
•
if you have HIGH BLOOD PRESSURE or HEART DISEASE
•
if you have KIDNEY DISEASE or HYPEREXCITABILITY
•
if you have DIFFICULTY BREATHING or LUNG PROBLEMS
•
if you are taking APPETITE SUPPRESSANTS or
STIMULANT DRUGS called amphetamines (sometimes
used to treat ADHD)
•
if you have taken monoamine oxidase inhibitors
(MAOls) prescribed for DEPRESSION in the LAST
TWO WEEKS
•
SUDDEN ABDOMINAL PAIN OR RECTAL BLEEDING may
occur with Day Nurse capsules, due to inflammation
of the colon (ischaemic colitis). If you develop these
gastro-intestinal symptoms, stop taking Day Nurse
capsules and contact your doctor or seek medical
attention immediately. See section 4
•
if you are taking ANTIBIOTICS CA

Fachinformation

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Day Nurse Capsules
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient
mg/cap
Paracetamol
500
Pseudoephedrine Hydrochloride
30
Pholcodine
5
For excipients, see 6.1.
3
PHARMACEUTICAL FORM
Capsule, hard
The Capsule has an orange cap and yellow body printed axially in black
ink ‘Day
Nurse’ on the cap and the body.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the relief of the symptoms of colds and influenza.
For oral administration.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Take during the day.
Should not be used with other paracetamol-containing products,
decongestants
or cough and cold medicines.
Adults and Children over 16 years
Two capsules every four hours, up to a maximum of 4 doses in 24 hours
if
needed, or up to a maximum of three doses within any 24 hour period if
a
night-time paracetamol-containing product is taken before bedtime.
Minimum
dosing interval: 4 hours. Do not exceed the stated dose. Do not use
for longer
than 7 days unless your doctor agrees.
Use the lowest amount needed to achieve benefit for the shortest
duration of
treatment.
Children under 16 years
Not to be given to children under sixteen years of age.
Elderly
There is no specific requirement for dosage reduction in the elderly.
4.3
CONTRAINDICATIONS
The product is contraindicated in patients with:
•
Hypersensitivity to any of the ingredients or excipients.
•
Severe hypertension or coronary artery disease.
•
Severe renal impairment.
•
Hyperexcitability.
•
With or at risk of developing, respiratory failure (e.g. those with
chronic obstructive airways disease or pneumonia) or those with
bronchiolitis or bronchiectasis due to sputum retention.
•
Who are receiving other sympathomimetics (such as decongestants,
appetite suppressants and amphetamine-like medicines).
•
Who are receiving Monoamine Oxidase Inhibitors (MAOIs) or for
two weeks after stopping a MAOI drug.
•
Who are taking oxazolidinone class of antibiotics (including
linezolid).
�